[1]
J. J. Jalbert, “EFFECT OF AN INSTITUTIONAL MEDICATION ADHERENCE PROGRAM FOR LONG-ACTING INJECTABLE RISPERIDONE ON ADHERENCE AND PSYCHIATRIC HOSPITALIZATIONS: EVIDENCE FROM A PROSPECTIVE COHORT STUDY”, J Popl Ther Clin Pharmacol, vol. 24, no. 2, pp. e61-e70, Jun. 2017, doi: 10.22374/1710-6222.24.2.7.